Rosa
Device Hips
PDI 00889024619401
General payments
$1,581,042
Research payments
$58,048
Through program year 2025, $1,581,042 in general payments and $58,048 in research payments were reported against Rosa (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $624,562 | 313 |
| 2025 | Research | $28,793 | 6 |
| 2024 | General | $641,907 | 235 |
| 2024 | Research | $29,255 | 3 |
| 2023 | General | $203,968 | 249 |
| 2022 | General | $110,605 | 349 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,146 general · 9 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.